|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Capnia, Inc.
| Capnia, Inc. 1235 Radio Road, Suite 110 Redwood City, CA 94065 | |
| | Phone: | (650) 213-8444 | Fax: | (650) 213-8383 | Year Established: | 1999 | Ticker: | CAPN | Exchange: | NASDAQ | Main Contact: | Edward Ebbers, CCO | | Other Contacts: | Kristen Yen, VP, Clinical & Regulatory Affairs Gina Phelps, VP, Sales Anish Bhatnagar, MD, CEO David O'Toole, CFO Anthony "Tony" Wondka, VP, R&D
| | Company Description | Capnia develops and commercializes novel products based on its proprietary technologies for precision metering of gas flow. Capnia's lead product CoSense® is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. Capnia's proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms of allergies, as well as the trigeminally mediated pain conditions such as cluster headache, trigeminal neuralgia and migraine. | |
|
|
|
|
|